• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Physiological function and Molecular mechanism of regulation by the CIS/JAB family members

Research Project

Project/Area Number 11694329
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Functional biochemistry
Research InstitutionKurume University

Principal Investigator

YOSHIMURA Akihkio  Kurume University Institute of Life Science Professor, 分子生命科学研究所, 教授 (90182815)

Co-Investigator(Kenkyū-buntansha) KAI Hisashi  Kurume University School of Medicine Assistant Professor, 医学部, 助手 (60281531)
MINOGUCHI Shigeru  Kurume University Institute of Life Science Assistant Professor, 分子生命科学研究所, 助手 (60322757)
WAKIOKA Toru  Kurume University Institute of Life Science Assistant Professor, 分子生命科学研究所, 助手 (40330873)
JAMES Ihle  St, Jude Children's Hospital, 部長
MATSUMOTO Akira  Kurume University Institute of Life Science Post-doctoral fellow, 分子生命科学研究所, 日本学術振興会特別研究員(PD)
IHLE James  St.Jude Children's Hospital Director of Biochemistry
安川 秀雄  久留米大学, 分子生命科学研究所, 助手 (60289361)
大坪 素秋  久留米大学, 分子生命科学研究所, 助手 (10211799)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥8,000,000 (Direct Cost: ¥8,000,000)
Fiscal Year 2000: ¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 1999: ¥4,200,000 (Direct Cost: ¥4,200,000)
Keywordstyrosine kinase / JAK / STAT / CIS / cytokine / knockout mice / tyrosine phosphorylation / kinase inhibitor
Research Abstract

Immune and inflammatory systems are controlled by multiple cytokines, including interleukins (ILs) and interferons. These cytokines exert their biological functions through Janus tyrosine kinases and STAT transcription factors. We recently identified two intrinsic JAK inhibitors, JAB (also referred to as SOCS1/SSI1) and CIS3 (or SOCS3/SSI3), which play an essential role in the negative regulation of cytokine signaling. We have shown that JAB is strongly induced by interferon-γ. JAB deficient mice die perinatally with altered lymphoid development including the generation of activated T cells in vivo. The lethality is eliminated on a Rag2 or interferon-γdeficient background. Based on the results, we propose that JAB plays an essential role in negative feedback regulation of interferon-γ.
During embryonic development CIS3 is highly expressed in some but not all erythroid lineage cells of the fetal liver. Deletion of CIS3 gene results in an embryonic lethality at 12-16 days that is associat … More ed with a marked erythrocytosis. Moreover, the individual in vitro proliferative capacity of fetal liver progenitors is greatly increased. The results suggest a specific negative regulatory effect of CIS3 on EPO signaling. We have investigated the role of STATs and these JAK inhibitors in intestinal inflammation. Among STAT family members, we found that STAT3 showed the strongest tyrosine phosphorylation in human ulcerative colitis and Crohn's disease patients as well as in dextran sulfate sodium (DSS)-induced colitis in mice. Development of DSS-induced colitis as well as STAT3 activation was significantly reduced in IL6-deficient mice, suggesting that STAT3 plays an important role in the perpetuation of colitis. CIS3, but not JAB, was highly expressed in the colon of DSS-treated mice. To define the physiological role of CIS3 induction in colitis, we developed a JAB mutant (F59D-JAB) that overcame the inhibitory effect of both JAB and CIS3 and created transgenic mice. DSS induced stronger STAT3 activation and more severe colitis in F59D-JAB-transgenic mice than in their wild-type littermates. These data suggest that hyperactivation of STAT3 results in severe colitis and that CIS3 plays a negative regulatory role in acute intestinal inflammation by down-regulating STAT3 activity. Less

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Suzuki A, et al.: "CIS3/SOCS3/SSI3 Plays a Negative Regulatory Role in STAT3 Activation and Intestinal Inflammation."J.Exp.Med.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kamizono S, et al.: "The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2."J.Biol.Chem.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sporri B, et al.: "JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling."Blood. 97. 221-226 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sasaki A, et al.: "CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2."J.Biol.Chem.. 275. 29338-29347 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwamoto T, et al.: "The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation."Oncogene. 19. 4795-4801 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masuhara M, et al.: "Molecular cloning of murine STAP-1, the stem cell-specific adaptor protein containing PH and SH2 domains."Biochem.Biophys.Res.Commun.. 268. 697-703 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Suzuki A, et al.: "CIS3/SOCS3/SSI3 Plays a Negative Regulatory Role in STAT3 Activation and Intestinal Inflammation."J.Exp. Med.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kamizono S, et al.: "The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2."J.Biol. Chem.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sporri B, et al.: "JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling."Blood. 97,1. 221-226 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sasaki A, et al.: "CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2."J.Biol. Chem.. 275,38. 29338-29347 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwamoto T, et al.: "The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation."Oncogene. 19, 41. 4795-4801 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masuhara M, et al.: "Molecular cloning of murine STAP-1, the stem cell-specific adaptor protein containing PH and SH2 domains."Biochem. Biophys. Res. Commun.. 268,3. 697-703 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Suzuki A, et al.: "CIS3/SOCS3/SSI3 Plays a Negative Regulatory Role in STAT3 Activation and Intestinal Inflammation."J.Exp.Med.. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] Kamizono S, et al.: "The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2."J.Biol.Chem.. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] Sporri B, et al.: "JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling."Blood. 97・1. 221-226 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sasaki A, et al.: "CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2."J.Biol.Chem.. 275・38. 29338-29347 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Iwamoto T, et al.: "The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation."Oncogene. 19・41. 4795-4801 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Masuhara M, et al.: "Molecular cloning of murine STAP-1, the stem cell-specific adaptor protein containing PH and SH2 domains."Biochem.Biophys.Res.Commun.. 268・3. 697-703 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Marine JC,et al.: "SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality."Cell. 98・5. 609-616 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Marine JC,et al.: "SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis."Cell. 98・5. 617-627 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yokouchi M,et al.: "Ligand-induced Ubiquitination of the EGF Receptor Involves the Interaction of the c-Cb1 RING Finger and UbcH7."J.Biol.Chem.. 274・44. 31707-31712 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Aman MJ,et al.: "CIS Associates with the Interleukin-2 Receptor beta Chain and Inhibits IL-2-Dependent Signaling"J.Biol.Chem.. 274・42. 30266-30272 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Cassatella MA,et al.: "Interleukin-10 (IL-10) Selectively Enhances CIS3/SOCS3 mRNA Expression in Human Neutrophils:Evidence for an IL-10-Induced Pathway That Is Independent of STAT Protein Activation."Blood. 94・8. 2880-2889 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Cohney SJ,et al.: "SOCS-3 Is Tyrosine Phosphorylated in Response to Interleukin-2 and Suppresses STAT5 Phosphorylation and Lymphocyte Proliferation."Mol.Cell.Biol.. 19・7. 4980-4988 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi